{"id":403303,"date":"2020-12-20T14:09:51","date_gmt":"2020-12-20T19:09:51","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=403303"},"modified":"2020-12-20T14:09:51","modified_gmt":"2020-12-20T19:09:51","slug":"johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\/","title":{"rendered":"Johnson Fistel, LLP Files Class Action Suit Against GoodRx (GDRX)"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n SAN DIEGO<\/span>, Dec. 20, 2020<\/span> \/PRNewswire\/ — Johnson Fistel<\/span>, LLP announces that a class action lawsuit has commenced on behalf of shareholders of GoodRx Holdings, Inc. (NASDAQ: GDRX) Class A common stock. \u00a0The class action is on behalf of shareholders who purchased GoodRx\u00a0between September 23, 2020<\/span> and November 16, 2020<\/span>, both dates inclusive (the “Class Period”). If you wish to serve as lead plaintiff in this class action, you must move the Court no later than February 16, 2021<\/span><\/b>.<\/p>\n

[Click here to join this action<\/a><\/b>]<\/p>\n

The GoodRx class action lawsuit charges GoodRx and certain of its officers and directors with violations of the Securities Exchange Act of 1934. GoodRx provides consumers with free information and tools that allow them to compare prices and save on their prescription drug purchases. The Company provides its users with these services via apps and websites that display prices and discounts at local and mail-order pharmacies for both insured and uninsured Americans.<\/p>\n

On August 28, 2020<\/span>, GoodRx filed with the SEC a Form S-1 Registration Statement (the “Registration Statement”) for its initial public offering (“IPO”), which was declared effective by the SEC on September 22, 2020<\/span>. On September 24, 2020<\/span>, GoodRx filed with the SEC its Prospectus for the IPO offering to sell to the public over 23.4 million Class A shares by the Company (excluding the underwriters’ option to purchase an additional 5.2 million common shares) and 11.2 million common shares by certain selling stockholders. On September 25, 2020<\/span>, GoodRx closed its IPO. In the offering, the Company and certain existing stockholders sold over 39.8 million common shares for $33<\/span> per share, including the full exercise of the underwriters’ option, generating over $1.3 billion<\/span> in gross offering proceeds.<\/p>\n

The complaint alleges that, at the time of the IPO, unbeknownst to investors, Amazon.com, Inc. (“Amazon”) was developing and would soon introduce its own online and mobile prescription medication ordering and fulfillment service that would directly compete with GoodRx. Defendants timed the IPO so that it was priced before Amazon announced its online pharmaceutical business to facilitate the IPO and create artificial demand for the common shares sold therein to maximize the amount of money the Company and the selling stockholders could raise in the IPO. Given defendants’ knowledge of Amazon’s intention to enter the online pharmaceutical business, their statements in the Registration Statement and during the Class Period about GoodRx’s competitive position were materially false and misleading when made and caused GoodRx Class A common stock to trade at artificially inflated prices of more than $64<\/span> per share during the Class Period.<\/p>\n

Then on November 17, 2020<\/span>, just weeks after GoodRx completed its IPO, Amazon announced two new pharmacy offerings, a Prime Rx plan and a discount card program, which, among other things, would compete directly with GoodRx’s platform by making it “simple for customers to compare prices and purchase medications for home delivery, all in one place.” In response to this news, the price of GoodRx Class A common stock declined 23%, from $46.72<\/span> per share to $36.21<\/span> per share by market close on November 17, 2020<\/span>.<\/p>\n

\u00a0A lead plaintiff will act on behalf of all other class members in directing the\u00a0GoodRx\u00a0class action lawsuit.\u00a0 The lead plaintiff can select a law firm of its choice to litigate the\u00a0GoodRx\u00a0class-action lawsuit.\u00a0 An investor’s ability to share any potential future recovery of the\u00a0GoodRx\u00a0class action lawsuit is not dependent upon serving as lead plaintiff.\u00a0 If you are interested in learning more about the case, please contact Jim Baker<\/span> (jimb@johnsonfistel.com<\/a>) at 619-814-4471<\/a>. \u00a0If you email, please include your phone number.<\/b><\/p>\n

Additionally, you can [Click here to join this action<\/a><\/b>]. There is no cost or obligation to you.<\/p>\n

\n About Johnson Fistel<\/span>, LLP:
<\/b>
\n Johnson Fistel<\/span>, LLP is a nationally recognized shareholder rights law firm with offices in California<\/span>, New York<\/span> and Georgia<\/span>. \u00a0The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. \u00a0For more information about the firm and its attorneys, please visit http:\/\/www.johnsonfistel.com<\/a>. \u00a0Attorney advertising. \u00a0Past results do not guarantee future outcomes.<\/p>\n

\n Contact:
<\/b>
\n Johnson Fistel<\/span>, LLP
Jim Baker<\/span>, 619-814-4471\u00a0
jimb@johnsonfistel.com<\/a><\/p>\n

\n \"Cision\" View original content:http:\/\/www.prnewswire.com\/news-releases\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx-301196429.html<\/a><\/p>\n

SOURCE Johnson Fistel<\/span>, LLP<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire SAN DIEGO, Dec. 20, 2020 \/PRNewswire\/ — Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of shareholders of GoodRx Holdings, Inc. (NASDAQ: GDRX) Class A common stock. \u00a0The class action is on behalf of shareholders who purchased GoodRx\u00a0between September 23, 2020 and November 16, 2020, both dates inclusive (the “Class Period”). If you wish to serve as lead plaintiff in this class action, you must move the Court no later than February 16, 2021. [Click here to join this action] The GoodRx class action lawsuit charges GoodRx and certain of its officers and directors with violations of the Securities Exchange Act of 1934. GoodRx provides consumers with free information and tools that allow … <\/p>\n

Continue reading “Johnson Fistel, LLP Files Class Action Suit Against GoodRx (GDRX)”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-403303","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nJohnson Fistel, LLP Files Class Action Suit Against GoodRx (GDRX) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Johnson Fistel, LLP Files Class Action Suit Against GoodRx (GDRX) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SAN DIEGO, Dec. 20, 2020 \/PRNewswire\/ — Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of shareholders of GoodRx Holdings, Inc. (NASDAQ: GDRX) Class A common stock. \u00a0The class action is on behalf of shareholders who purchased GoodRx\u00a0between September 23, 2020 and November 16, 2020, both dates inclusive (the “Class Period”). If you wish to serve as lead plaintiff in this class action, you must move the Court no later than February 16, 2021. [Click here to join this action] The GoodRx class action lawsuit charges GoodRx and certain of its officers and directors with violations of the Securities Exchange Act of 1934. GoodRx provides consumers with free information and tools that allow … Continue reading "Johnson Fistel, LLP Files Class Action Suit Against GoodRx (GDRX)"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-20T19:09:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH30113&sd=2020-12-20\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Johnson Fistel, LLP Files Class Action Suit Against GoodRx (GDRX)\",\"datePublished\":\"2020-12-20T19:09:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\\\/\"},\"wordCount\":687,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=PH30113&sd=2020-12-20\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\\\/\",\"name\":\"Johnson Fistel, LLP Files Class Action Suit Against GoodRx (GDRX) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=PH30113&sd=2020-12-20\",\"datePublished\":\"2020-12-20T19:09:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=PH30113&sd=2020-12-20\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=PH30113&sd=2020-12-20\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Johnson Fistel, LLP Files Class Action Suit Against GoodRx (GDRX)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Johnson Fistel, LLP Files Class Action Suit Against GoodRx (GDRX) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\/","og_locale":"en_US","og_type":"article","og_title":"Johnson Fistel, LLP Files Class Action Suit Against GoodRx (GDRX) - Market Newsdesk","og_description":"PR Newswire SAN DIEGO, Dec. 20, 2020 \/PRNewswire\/ — Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of shareholders of GoodRx Holdings, Inc. (NASDAQ: GDRX) Class A common stock. \u00a0The class action is on behalf of shareholders who purchased GoodRx\u00a0between September 23, 2020 and November 16, 2020, both dates inclusive (the “Class Period”). If you wish to serve as lead plaintiff in this class action, you must move the Court no later than February 16, 2021. [Click here to join this action] The GoodRx class action lawsuit charges GoodRx and certain of its officers and directors with violations of the Securities Exchange Act of 1934. GoodRx provides consumers with free information and tools that allow … Continue reading \"Johnson Fistel, LLP Files Class Action Suit Against GoodRx (GDRX)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-20T19:09:51+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH30113&sd=2020-12-20","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Johnson Fistel, LLP Files Class Action Suit Against GoodRx (GDRX)","datePublished":"2020-12-20T19:09:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\/"},"wordCount":687,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH30113&sd=2020-12-20","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\/","name":"Johnson Fistel, LLP Files Class Action Suit Against GoodRx (GDRX) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH30113&sd=2020-12-20","datePublished":"2020-12-20T19:09:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH30113&sd=2020-12-20","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH30113&sd=2020-12-20"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-fistel-llp-files-class-action-suit-against-goodrx-gdrx\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Johnson Fistel, LLP Files Class Action Suit Against GoodRx (GDRX)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/403303","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=403303"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/403303\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=403303"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=403303"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=403303"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}